SCHEMBL13469348

SCHEMBL13469348

CCc1cccc(S(=O)(=O)NC2CC2)c1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
LMNA P02545 3/20 0.58
KMT2A Q03164 3/20 0.51
BRD4 O60885 3/20 0.51
BRD2 P25440 1/20 0.51
BRD3 Q15059 1/20 0.51
TDP1 Q9NUW8 1/20 0.50
PARG Q86W56 1/20 0.50
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
RECQL P46063 1/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14376189 0.94 ALDH1A1 (0.56) ALDH1A1LMNAKMT2ACYP3A4TSHR
SCHEMBL15899804 0.84 ALDH1A1 (0.55) ALDH1A1LMNAKMT2ABRD4BRD2
SCHEMBL14249971 0.84 ALDH1A1 (0.58) ALDH1A1LMNAKMT2ABRD4BRD2
SCHEMBL14314606 0.84 ALDH1A1 (0.55) ALDH1A1LMNAKMT2ABRD4BRD2
SCHEMBL14250451 0.84 ALDH1A1 (0.55) ALDH1A1LMNAKMT2ABRD4BRD2
SCHEMBL27885422 0.82 ALDH1A1 (0.52) ALDH1A1LMNAKMT2ABRD4BRD2
SCHEMBL18151417 0.81 ALDH1A1 (0.58) ALDH1A1LMNAKMT2ABRD4BRD2
SCHEMBL8272934 0.80 SMN1; SMN2 (0.61) ALDH1A1LMNAKMT2ATDP1CYP3A4
SCHEMBL14376188 0.79 GBA1 (0.62) ALDH1A1KMT2APARGSMN1; SMN2TP53
SCHEMBL11992039 0.79 ALDH1A1 (0.63) ALDH1A1LMNAKMT2ABRD4BRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044778-A2 NOVEL MODULATORS OF FSHR AND USES THEREOF CELMATIX INC. (US) 2024-02-29 WO disclosed
US-20170360788-A1 SMALL MOLECULE INHIBITORS OF EGFR AND PI3K THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2017-12-21 US disclosed
US-20170197910-A1 SUBSTITUTED VINYL AND ALKYNYL CYANOCYCLOALKANOLS AND VINYL AND ALKYNYL CYANOHETEROCYCLOALKANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-07-13 US disclosed
WO-2016008862-A1 SUBSTITUTED VINYL AND ALKYNYL CYANOCYCLOALKANOLS AND VINYL AND ALKYNYL CYANOHETEROCYCLOALKANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-01-21 WO disclosed
US-9034900-B2 Bromodomain inhibitors Quanticel Pharmaceuticals, Inc. (US) 2015-05-19 US disclosed
WO-2012139891-A1 SUBSTITUTED VINYL AND ALKINYL CYCLOHEXENOLS AS ACTIVE AGENTS AGAINST ABIOTIC STRESS IN PLANTS BAYER CROPSCIENCE AG (DE) 2012-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170360788-A1 SMALL MOLECULE INHIBITORS OF EGFR AND PI3K EGFR, ERBB2, ERBB3 ALDH1A1 4653/4885LMNA 4781/4885KMT2A 2786/4885
US-20170197910-A1 SUBSTITUTED VINYL AND ALKYNYL CYANOCYCLOALKANOLS AND VINYL AND ALKYNYL CYANOHETEROCYCLOALKANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS CBR1, CBR3, VRK1 ALDH1A1 1954/4885LMNA 748/4885KMT2A 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.